{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:01:35Z","timestamp":1768082495263,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"New Century Excellent Talents Project of Education Ministry","award":["NCET-13-0936"],"award-info":[{"award-number":["NCET-13-0936"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2950-7","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:21:20Z","timestamp":1540027280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Ying","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-5946","authenticated-orcid":false,"given":"Wenke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"issue":"21","key":"2950_CR1","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1093\/eurheartj\/ehl257","volume":"27","author":"EI kalidis","year":"2006","unstructured":"kalidis EI, Vardas PE. Guidelines on the management of stable angina pectoris. Eur Heart J. 2006;27(21):2606\u20137.","journal-title":"Eur Heart J"},{"issue":"12","key":"2950_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.je.2016.12.019","volume":"27","author":"D Ma","year":"2017","unstructured":"Ma D, Sakai H, Wakabayashi C, et al. The prevalence and risk factor control associated with noncommunicable diseases in China, Japan, and Korea. J Epidemiol. 2017;27(12):568\u201373.","journal-title":"J Epidemiol"},{"issue":"4","key":"2950_CR3","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38\u2013360. \n                    https:\/\/doi.org\/10.1161\/CIR\n                    \n                  .","journal-title":"Circulation"},{"key":"2950_CR4","first-page":"23","volume-title":"Clinical applications of cardiac CT","author":"TSS Genders","year":"2012","unstructured":"Genders TSS, Hunink MGM. Epidemiology of coronary artery disease. In: Cademartiri F, Casolo G, Midiri M, editors. Clinical applications of cardiac CT. Milan: Springer; 2012. p. 23\u20137."},{"key":"2950_CR5","volume-title":"Morbidity & Mortality: 2012 chart book on cardiovascular, lung, and blood diseases","author":"National Institutes of Health National Heart, Lung, and Blood Institute","year":"2012","unstructured":"National Institutes of Health National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2012 chart book on cardiovascular, lung, and blood diseases. Bethesda: National Heart, Lung, and Blood Institute; 2012."},{"issue":"2","key":"2950_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jep.2011.08.071","volume":"141","author":"ZY Gao","year":"2012","unstructured":"Gao ZY, Xu H, Shi DZ, et al. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. J Ethnopharmacol. 2012;141(2):578\u201383.","journal-title":"J Ethnopharmacol"},{"key":"2950_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00029330-200601010-00002","volume":"119","author":"KJ Chen","year":"2006","unstructured":"Chen KJ, Shi DZ, Xu H, Lv SZ, Li TC, Ke YN, et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chin Med J. 2006;119:6\u201313.","journal-title":"Chin Med J"},{"issue":"04","key":"2950_CR8","first-page":"227","volume":"30","author":"YB Ge","year":"2011","unstructured":"Ge YB, Mao JY. Analysis of distribution of TCM syndromes in 7512 patients with coronary heart diseases. Shandong J Tradit Chin Med. 2011;30(04):227\u20139.","journal-title":"Shandong J Tradit Chin Med"},{"issue":"03","key":"2950_CR9","first-page":"307","volume":"29","author":"S Zhag","year":"2017","unstructured":"Zhag S, LI Z, Cao L, et al. Meta-analysis of reinforcing Qi and activating blood recipe for coronary eart disease. J Cardiac. 2017;29(03):307\u201312.","journal-title":"J Cardiac"},{"key":"2950_CR10","first-page":"15","volume":"10","author":"XJ Xiong","year":"2014","unstructured":"Xiong XJ, Wang Z, Wang J. Innovative strategy in treating angina pectoris with Chinese patent medicines by promoting blood circulation and removing blood stasis: experience from combination therapy in Chinese medicine. Curr Vasc Pharmacol. 2014;10:15.","journal-title":"Curr Vasc Pharmacol"},{"key":"2950_CR11","unstructured":"Zhang GQ, Wang YY, Yan GZ. Research on the pharmacodynamics of Guanxinjing oral liquid. J Hebei Med Coll. 1995;16(02):73\u20134."},{"key":"2950_CR12","first-page":"133134","volume":"S1","author":"SJ Song","year":"2014","unstructured":"Song SJ, Wei FJ, Wei TY, et al. The effect of Guanxinjing capsule on the treatment of qi deficiency and blood stasis type coronary heart disease. China Pharm Econ. 2014;S1:133134.","journal-title":"China Pharm Econ"},{"issue":"1","key":"2950_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/hrt.2004.059451","volume":"92","author":"P de Jonge","year":"2006","unstructured":"de Jonge P, Spijkerman TA, van den Brink RH, Ormel J. Depression after myocardial infarction is a risk factor for declining health related quality of life and increased disability and cardiac complaints at 12 months. Heart. 2006;92(1):32\u20139.","journal-title":"Heart"},{"issue":"3","key":"2950_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.genhosppsych.2011.02.007","volume":"33","author":"A Meijer","year":"2011","unstructured":"Meijer A, Conradi HJ, Bos EH, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33(3):203.","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"2950_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.psy.0000146332.53619.b2","volume":"66","author":"J Barth","year":"2004","unstructured":"Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66(6):802\u201313.","journal-title":"Psychosom Med"},{"issue":"6","key":"2950_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/NDT.S6880","volume":"6","author":"JC Huffman","year":"2010","unstructured":"Huffman JC, Celano CM, Januzzi JL. The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes. Neuropsychiatr Dis Treat. 2010;6(6):123\u201336.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"2950_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/CIRCOUTCOMES.111.000049","volume":"6","author":"CM Celano","year":"2013","unstructured":"Celano CM, Suarez L, Mastromauro C, Januzzi JL, Huffman JC. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2013;6(4):498\u2013504.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"2950_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1467-9450.1996.tb00657.x","volume":"37","author":"DF Smith","year":"2010","unstructured":"Smith DF, Sterndorff B, R\u00f8pcke G, et al. Prevalence and severity of anxiety, depression and Type A behaviors in angina pectoris. Scand J Psychol. 2010;37(3):249\u201358.","journal-title":"Scand J Psychol"},{"issue":"1","key":"2950_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12160-014-9629-4","volume":"49","author":"R Trivedi","year":"2015","unstructured":"Trivedi R, Gerrity M, Rumsfeld JS, et al. Angina symptom burden associated with depression status among veterans with ischemic heart disease. Ann Behav Med. 2015;49(1):58\u201365.","journal-title":"Ann Behav Med"},{"issue":"8","key":"2950_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00392-013-0568-z","volume":"102","author":"L Jespersen","year":"2013","unstructured":"Jespersen L, Abildstr\u00f8m SZ, Hvelplund A, et al. Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clin Res Cardiol. 2013;102(8):571\u201381.","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"2950_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/01.psy.0000133362.75075.a6","volume":"66","author":"RM Carney","year":"2004","unstructured":"Carney RM, Blumenthal JA, Freedland KE, Youngblood M, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004;66(4):466.","journal-title":"Psychosom Med"},{"key":"2950_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jama.297.4.367","volume":"297","author":"F Lesperance","year":"2007","unstructured":"Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial. JAMA. 2007;297:367\u201379.","journal-title":"JAMA."},{"key":"2950_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/PSY.0b013e31814b260d","volume":"69","author":"A Honig","year":"2007","unstructured":"Honig A, Kuyper AMG, Schene AH, et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med. 2007;69:606\u201313.","journal-title":"Psychosom Med"},{"issue":"04","key":"2950_CR24","first-page":"434","volume":"5","author":"HX Liu","year":"2013","unstructured":"Liu HX. Report of the research on the treatment mechanism of Guanxinjing capsule in myocardial infarction with depression disorder. Chin J Evid Based Cardiovasc Med. 2013;5(04):434.","journal-title":"Chin J Evid Based Cardiovasc Med"},{"key":"2950_CR25","unstructured":"Wang X, Qin Z, Zhao ZF. A consensus on the diagnosis and treatment of depression before and after percutaneous coronary intervention (PCI). J Tradit Chin Med. 2015;56(04):357\u201360."},{"issue":"03","key":"2950_CR26","first-page":"198","volume":"27","author":"L Wang","year":"2014","unstructured":"Wang L, Lu K, Wang CY, et al. Analysis of reliability and validity of GAD-2 and GAD-7 in cardiovascular anxiety screening. Sichuan Mental Health. 2014;27(03):198\u2013201.","journal-title":"Sichuan Mental Health"},{"issue":"10","key":"2950_CR27","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"2","key":"2950_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/M16-2977","volume":"167","author":"C-w Cheng","year":"2017","unstructured":"Cheng C-w, Tai-xiang W, Shang H-c, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med. 2017;167(2):112\u201321.","journal-title":"Ann Intern Med"},{"key":"2950_CR29","unstructured":"Cardiology Branch of Chinese Medical Association. The guideline on diagnosis and treatment of chronic stability angina. Chin J Cardiovasc Dis. 2007;35;(03):195\u2013206."},{"issue":"38","key":"2950_CR30","first-page":"2949\u20133003","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949\u20133003.","journal-title":"Eur Heart J"},{"key":"2950_CR31","unstructured":"Healthcare Improvement Scotland. Management of stable angina. Coronary revascularisation in the management of stable angina pectoris (SIGN Guideline). Edinburgh: Healthcare Improvement Scotland; 2018\u201304\/2018-06-04. \n                    http:\/\/www.sign.ac.uk\n                    \n                  ."},{"key":"2950_CR32","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/circ.54.3.947585","volume":"54","author":"L Campeau","year":"1976","unstructured":"Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54:522\u20133.","journal-title":"Circulation"},{"key":"2950_CR33","unstructured":"China Food and Drug Administration. Technical guidelines for clinical research on the treatment of angina pectoris by traditional Chinese medicine and natural medicine. \n                    http:\/\/www.sda.gov.cn\/WS01\/CL1616\/90942.html.2011.07.08\n                    \n                  ."},{"issue":"8","key":"2950_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/CIR.0b013e31829b5b44","volume":"128","author":"GF Fletcher","year":"2013","unstructured":"Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873\u2013934.","journal-title":"Circulation"},{"issue":"26","key":"2950_CR35","first-page":"2562","volume":"47","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Global status report on noncommunicable diseases 2014. Women. 2014;47(26):2562\u20133.","journal-title":"Women"},{"issue":"2","key":"2950_CR36","first-page":"270","volume":"33","author":"XL Wang","year":"2013","unstructured":"Wang XL, Mao JY, Hou YZ. Preliminary study of establishing clinical effect evaluation methods of Chinese medicine based on combination of disease and syndrome, systematic staging, and multi-dimension index. Chin J Integr Tradit West Med. 2013;33(2):270.","journal-title":"Chin J Integr Tradit West Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2950-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2950-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2950-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T19:21:29Z","timestamp":1571512889000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2950-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2950-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This trial protocol was approved by the Ethics Committee of the Tianjin University of TCM (ChiCTR1800014258). The study protocol and informed consent are consistent with scientific and ethical requirements. Written informed consent (see Additional file ) must be obtained from all participants or their legally authorized representatives before enrolment. Study participation is voluntary and can be cancelled at any time without provision of reasons and without negative consequences for their future medical care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We will give informed consent for the publication of the dataset from patients at the point of recruitment to the trial. All the patient details will be fully anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"577"}}